1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Respiratory Therapy News OCTOBER 2014

Respiratory Therapy News OCTOBER 2014

  • October 2014
  • -
  • Espicom Business Intelligence
  • -
  • 28 pages

Industry Trend Analysis - Respiratory Market Stratification Inevitable, Augmented By ERS Revelations
Industry Trend Analysis - Teva Follows De-Diversification Trend With Focus On CNS/Respiratory
Industry Trend Analysis - Race For First US IPF Treatment Is A Dead Heat
Industry Brief - Novavax Initiates Phase II Trial Of RSV F Vaccine
Industry Brief - Vibativ Now Available In Europe For HAP/VAP
Industry Trend Analysis - BI Enhances Oncology Pipeline With CureVac Agreement
Industry Brief - Anoro Ellipta Improved Lung Function Compared With Tiotropium
Industry Brief - FDA Accepts BLA For Merck/Sanofi Pasteur's Paediatric Hexavalent Vaccine
Industry Trend Analysis - Breakthrough Designation Signals More Positive Future For ARIAD
Industry Trend Analysis - J&J Bolsters Immunotherapy Pipeline With Second Aduro Collaboration
Industry Brief - FDA Advisory Committee Recommends Kalydeco Approval
Industry Brief - Ansun Reports Data On Clinical Activity Of ParaDase
Industry Brief - FDA Approves Spiriva Respimat Inhalation Spray For COPD
Industry Brief - FDA Grants SPA For Dalvance Phase III Study
Industry Brief - Novavax Initiates Phase II Trial Of RSV F Vaccine In Elderly Subjects
Industry Trend Analysis - Aesica Acquisition Augments Consort's Expansion Strategy
Industry Brief - Resminostat Phase II Study Initiated In Asian NSCLC Patients
Industry Brief - Novartis Enters Collaboration To Evaluate Opdivo In Combination Treatments For NSCLC
Industry Brief - Sunovion To Sell Xopenex Rights To Akorn
Industry Brief - Savara Raises Funds To Advance AeroVanc; Completes Phase II Trial Enrolment
Industry Brief - Novartis Enters Greek COPD Partnership With Pharmathen
Industry Brief - FDA Grants Fast Track Designation For MEDI3902 In Nosocomial Pneumonia
Industry Brief - Nintedanib IPF Study Results Presented
Industry Brief - Striverdi Respimat Available In US As COPD Maintenance Treatment
Industry Trend Analysis - Alios Acquisition Boosts J&J's HCV Combination Drug Capabilities
Industry Brief - Phase III Studies Of Teva's Reslizumab Show Utility In Eosinophilic Asthma
Industry Brief - Boehringer To Expand German Respimat Production
Industry Brief - Chiesi Launches Fostair NEXThaler For Adult Asthma
Industry Brief - InterMune Reports Positive Results From Pirfenidone Phase III Study in IPF
Industry Brief - Dr Reddy's Launches Levalbuterol Inhalation Solution In US
Industry Brief - CHMP Issues Positive Opinion On Aclidinium/Formoterol
Industry Brief - Cempra Completes Enrolment In Solithromycin Phase III Trial For CABP
Industry Trend Analysis - Multiple ODDs For CytRx Cover Three Areas Of Unmet Medical Need
Industry Brief - Cravit/Levofloxacin sNDA Submitted In Japan
Industry Trend Analysis - Blood-Based Diagnostic Opens New Market For Iressa
Industry Trend Analysis - Boehringer Ingelheim Close To Market With Second Oncology Drug
Industry Brief - Allied Minds Launches Novare Pharmaceuticals
Industry Trend Analysis - New Wave Of ALK Inhibitors Set To Enter Market
Industry Brief - MN-001 Gains US Orphan Drug Designation For IPF
Industry Brief - Duvelisib Phase IIa Study In Asthma Misses Primary Endpoint

Table Of Contents

Respiratory Therapy News OCTOBER 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.